Results 141 to 150 of about 1,208,876 (310)

Honolulu Area Metropolitan Map Series Pre-Enumeration Copy, Sheet 1, 1969 [PDF]

, 1969
Scale 1:24,000. 1 map ; 36 x 48.5 cm on sheet 47 x 61 cm. Pre-enumeration copy of census tracts for Honolulu.
United States. Bureau of the Census.
core  

Loss of proton‐sensing TDAG8 increases tumor progression in mouse models of colon cancer

Molecular Oncology, EarlyView.
Loss of the pH‐sensing receptor TDAG8 accelerates colorectal cancer progression in mice. Animals lacking TDAG8 expression had increased tumor growth, DNA damage, and recruitment of tumor‐associated immune cells, including macrophages, neutrophils, and monocytes.
Ermanno Malagola, Yasmine Illi, Anna Bircher, Marijn Wilmink, Rachele F. Malagutti, Solenn Ottié, Cordelia Schuler, Pedro A. Ruiz, Cheryl de Vallière, Klaus Seuwen, Gerhard Rogler, Martin Hausmann   +11 more
wiley   +1 more source

Honolulu Area Metropolitan Map Series Pre-Enumeration Copy, Sheet 20, 1969 [PDF]

, 1969
Scale 1:24,000. 1 map ; 36 x 48.5 cm on sheet 47 x 61 cm. Pre-enumeration copy of census tracts for Honolulu.
United States. Bureau of the Census.
core  

Epigenetic heterogeneity and plasticity in therapy‐induced tumor states through single‐cell multi‐omics

Molecular Oncology, EarlyView.
Single‐cell multi‐omics reveals epigenetic heterogeneity across therapy‐adaptive tumor states, including quiescent/dormant, drug‐tolerant persister, and EMT‐like phenotypes. By linking regulatory features with state‐associated biomarkers, these approaches inform biomarker‐guided therapeutic strategies for evolving tumors.
Hee Jung Kim, Hwiyeong Lee, Jin Hong, Daechan Park   +3 more
wiley   +1 more source

Honolulu Area Metropolitan Map Series Pre-Enumeration Copy, Index Map, 1969 [PDF]

, 1969
Scale 1:24,000. 1 map ; 36 x 48.5 cm on sheet 47 x 61 cm. Pre-enumeration copy of census tracts for Honolulu.
United States. Bureau of the Census.
core  

Inhibition of cyclin‐dependent kinases 12/13 using CT7439 as a treatment for colorectal cancer with CDK12 upregulation

Molecular Oncology, EarlyView.
The proposed mechanism of action for the CDK12/13 inhibitor and cyclin K degrader, CT7439. CDK12/13 inhibition interrupts transcription elongation, leading to increased DNA damage that results in cell death. This agent is a potentially novel treatment option for patients with colorectal cancer. Created in BioRender. Cyclin‐dependent kinase (CDK) 12 and
Wylie K. Watlington, Divya L. Dayanidhi, Mohammad Zokaasadi, John B. Mantyh, Pelumi D. Olawuni, Gabrielle Rupprecht, Jeremy M. Force, Shannon McCall, Ashwani K. Bahl, David S. Hsu, Jason A. Somarelli   +10 more
wiley   +1 more source

Auras migratoires

Perspective, 2022
Adam Lowe, Jean-Michel Frodon
doaj   +1 more source

Honolulu Area Metropolitan Map Series Pre-Enumeration Copy, Sheet 21, 1969 [PDF]

, 1969
Scale 1:24,000. 1 map ; 36 x 48.5 cm on sheet 47 x 61 cm. Pre-enumeration copy of census tracts for Honolulu.
United States. Bureau of the Census.
core  

In vitro and in silico modelling of ROS1‐positive non‐small cell lung cancer reveals fusion‐dependent tyrosine kinase inhibitor responses

Molecular Oncology, EarlyView.
Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq, Marc Terrones, Felicia Rodrigues Fortes, Anne Schepers, Alessia Denis, Christophe Deben, Ken Op de Beeck, Guy Van Camp, Geert Vandeweyer   +8 more
wiley   +1 more source

Altered copy [PDF]

, 2012
In 2008, Jenny Roche commissioned Jodi Melnick to make the solo Business of the Bloom on her. Four years later, Roche re-enters this piece and draws on their many years of working together to inhabits its ideas and impulses from a new perspective.
Roche, Jennifer
core